Trial intelligence / Profile preview

Phase 3 trial of topical benvitimod cream for mild to moderate plaque psoriasis

ChiCTR-TRC-13003259Phase 3Completed

Sponsor
Peking University People's Hospital
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of tapinarof in plaque psoriasis (3 arms), sponsored by Peking University People's Hospital. Primary endpoints: Physician's Global Assessment, Photographs of target plaques and 1 more. Started Mar 2013; status: completed.

02

Drugs

tapinarof
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on ChiCTR-TRC-13003259.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003259.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call